| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 |
| filingDate |
2018-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63594a2217d46aa193e25ef3c0b53883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8c28f578581089835e3a7e7c707e4de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0e7040ca913388d81755ea0b5794c31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36fa203528803894750e89d0dff8c540
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48726102e0425766602fce7544f3b0d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed921c85a08fe9ac27d4f82633ca3d4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e9d4df892ccf2f5dfb050626abfe7cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bed23e495d648967b0ee7a28ff1d1c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1f874193dd6c49ff45a2e35d641f541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f75de324432fd0db524f50b8839b2ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18834a186f63f5d5e4026c8eb0b9b678
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22f5d6157267edb7abbf0ba7ae73103b |
| publicationDate |
2018-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201828942-A |
| titleOfInvention |
Combination of MCL-1 inhibitor and taxane compound, use thereof and pharmaceutical composition |
| abstract |
The present invention relates to a combination comprising an MCL-1 inhibitor and a taxane compound, and a composition and use thereof. |
| priorityDate |
2017-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |